PedDx: An End-to-End Deep Learning Framework for Pediatric Posterior Fossa Tumor Diagnosis with Agentic AI–Enabled Independent External Evaluation
Source check: Source checked. Not independent scientific confirmation.
Finding: Results report five-class accuracy of 81.4% in the external CHOA cohort (88.7% among non-abstained cases) and 92.5% across 40 independently processed WCH cases (97.3% among non-abstained cases); WCH contained only three histologies, and the preprint also reports confidently incorrect OOD cases. Methods describe a frozen pretrained 3DINO backbone, multi-crop MRI sampling, calibrated class probabilities and confidence-based abstention; the deployed workflow also includes a quality-control agent. Testing: Methods/results distinguish discovery (n=492), replication (n=114), external CHOA (n=129) and independent WCH workflow cases (n=40), with pathology/clinical diagnoses and stated exclusions. The independent cohorts support the narrow diagnostic-performance result; small WCH sample, missing two histologies, unreviewed preprint and no evidence of improved patient outcomes limit interpretation.. Independent external evaluation of a pediatric posterior-fossa tumor MRI classifier and full workflow reports performance on separate CHOA and WCH cohorts; bounded to diagnostic classification, not clinical benefit. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.
Technology: Methods describe a frozen pretrained 3DINO backbone, multi-crop MRI sampling, calibrated class probabilities and confidence-based abstention; the deployed workflow also includes a quality-control agent.
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- Methods describe a frozen pretrained 3DINO backbone, multi-crop MRI sampling, calibrated class probabilities and confidence-based abstention; the deployed workflow also includes a quality-control agent.
- Test and result
- Methods/results distinguish discovery (n=492), replication (n=114), external CHOA (n=129) and independent WCH workflow cases (n=40), with pathology/clinical diagnoses and stated exclusions. The independent cohorts support the narrow diagnostic-performance result; small WCH sample, missing two histologies, unreviewed preprint and no evidence of improved patient outcomes limit interpretation.
- Limitation / still unknown
- Independent external evaluation of a pediatric posterior-fossa tumor MRI classifier and full workflow reports performance on separate CHOA and WCH cohorts; bounded to diagnostic classification, not clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.medrxiv.org/content/10.64898/2026.10.27.26366616v1.full.pdf · https://api.biorxiv.org/details/medrxiv/2026-10-29/2026-10-29/0
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.